Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line

R. N. Keswani, A. Chumsangsri, R. Mustafi, J. Delgado, E. E.W. Cohen, Marc Bissonnette

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science